Introduced by Sen. Goeff Hansen (R) on June 22, 2017
To impose a new coverage mandate that would require insurance companies to include coverage for orally administered chemotherapy in all their health insurance policies that provide for cancer chemotherapy treatments, without requiring any dollar limit, deductible or co-pay for these that does not apply to other treatments. Also, to prohibit an insurer from requiring a copayment greater than $100 for a 30 day supply of the pills. Official Text and Analysis.
Referred to the Senate Insurance Committee on June 22, 2017
Reported in the Senate on October 12, 2017
With the recommendation that the substitute (S-1) be adopted and that the bill then pass.